Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Select a Mutual Fund
Risk | Very High | - |
Rating | - | - |
Min SIP Amount | ₹100 | - |
Expense Ratio | 1.02 | - |
NAV | ₹10.26 | - |
Fund Started | 21 Aug 2024 | - |
Fund Size | ₹17.74 Cr | - |
Exit Load | Exit load of 0.25%, if redeemed within 15 days. | - |
Risk
Rating
Min SIP Amount
Expense Ratio
NAV
Fund Started
Fund Size
Exit Load
1 Year | 4.11% | - |
3 Year | - | - |
5 Year | - | - |
1 Year
3 Year
5 Year
Equity | 100.07% | - |
Cash | -0.07% | - |
Equity
Cash
Top 10 Holdings |
| - |
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 12.81% |
Cipla Ltd. | 6.37% |
Max Healthcare Institute Ltd. | 6.27% |
Apollo Hospitals Enterprise Ltd. | 5.67% |
Dr. Reddy's Laboratories Ltd. | 5.67% |
Divi's Laboratories Ltd. | 5.52% |
Fortis Healthcare Ltd. | 3.84% |
Lupin Ltd. | 3.52% |
Torrent Pharmaceuticals Ltd. | 2.87% |
Laurus Labs Ltd. | 2.49% |
Name | Nemish Sheth | - |
Start Date | 13 Feb 2025 | - |
Name
Start Date
Description | The scheme seeks to replicate the BSE Healthcare Index by investing in securities of the BSE Healthcare Index in the same proportion / weightage with an aim to provide returns before expenses that track the total return of BSE Healthcare Index, subject to tracking errors. | - |
Launch Date | 21 Aug 2024 | - |
Description
Launch Date